41 Biggest Movers From Yesterday

Gainers

• Ebang International Holdings Inc. EBON shares gained 35.4% to settle at $1.09 on Wednesday as investors weighed the Federal Reserve Reserve decision to leave rates unchanged.
• Eros STX Global Corporation ESGC shares gained 30.2% to close at $0.3674. ErosSTX, last month, agreed for sale of its STX Entertainment subsidiary to The Najafi Companies.
• Sierra Oncology, Inc. SRRA jumped 26.3% to close at $28.64 on Wednesday as the company reported a proposed public offering of $100 million of common stock.
• Stride, Inc. LRN shares jumped 25% to settle at $33.76 on Wednesday after the company reported better-than-expected Q2 results and issued Q3 guidance above estimates.
• Larimar Therapeutics, Inc. LRMR gained 21.3% to close at $10.50.
• Groupon, Inc. GRPN gained 20% to settle at $26.68 following Bloomberg report 'Payments Firm SumUp Seeks New Funds at $22 Billion Value.'
• Huadi International Group Co., Ltd. HUDI gained 19.8% to settle at $19.84.
• Rani Therapeutics Holdings, Inc. RANI surged 19.6% to close at $23.14.
• Evolus, Inc. EOLS jumped 17.3% to settle at $6.59. Evolus posted interim Q4 sales of approximately $34.7 million (better than the consensus of $30.87 million), up 68% Y/Y, driven by higher volumes and a higher average selling price.
• Exela Technologies, Inc. XELA shares gained 16.4% to close at $0.64 on Wednesday after the company announced a share buyback of up to 100 million shares of common stock at $1 per share through an exchange offer of new notes.
• Trebia Acquisition Corp. TREB jumped 14.3% to close at $10.48.
• Trebia Acquisition’s shareholders recently approved business combination with System1.
• Vasta Platform Limited VSTA rose 13.4% to settle at $5.17.
• Longeveron Inc. LGVN gained 13% to close at $7.99.
• Corning Incorporated GLW climbed 11.2% to close at $39.24 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 EPS and sales guidance above analyst estimates.
• Merrimack Pharmaceuticals, Inc. MACK climbed 7.9% to close at $4.9650.
• Genius Sports Limited GENI surged 7% to close at $6.26.
• DraftKings Inc. DKNG gained 5.2% to close at $20.33 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and announced a $31 price target.
• 180 Life Sciences Corp. ATNF gained 5.1% to close at $2.66.
• Marten Transport, Ltd. MRTN gained 4.6% to close at $16.92 after the company reported better-than-expected Q4 results.
• Mattel, Inc. MAT gained 4.3% to close at $20.46. Mattel signed a multi-year global licensing agreement with Walt Disney for the Disney Princess and Frozen franchises.

Latest Startup Investment Opportunities:

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these penny stocks insiders are buying

Losers

• Gatos Silver, Inc. GATO shares tumbled 68.9% to close at $3.17 on Wednesday after the company issued an update on mineral resources and reserves at Cerro Los Gatos and 2022 performance guidance. RBC Capital and CIBC downgraded the stock.
• Tyme Technologies, Inc. TYME dropped 37.5% to settle at $0.3315 after the company announced it will discontinue SM-88 with MPS in the Precision Promise trial in metastatic pancreatic cancer.
• Cortexyme, Inc. CRTX fell 31.5% to close at $6.21. The FDA placed a clinical hold on Cortexyme’s atuzaginstat (COR388) Investigational New Drug application (IND 134303).
• Mainz Biomed B.V. MYNZ dipped 28.4% to settle at $14.50 after the company priced a 1.5 million share follow-on offering at $15 per share.
• Volcon, Inc. VLCN fell 25.4% to close at $5.09. Volcon filed for offering of 3.5 million shares of common stock.
• Aptorum Group Limited APM dropped 24.9% to close at $1.69. Aptorum Group recently announced it received FDA Orphan Drug designation for its SACT-1 repurposed drug for the treatment of neuroblastoma.
• Indonesia Energy Corporation Limited INDO tumbled 18.1% to close at $2.80. Indonesia Energy said it projects to commence drilling of 2 back-to-back new wells within 30 days and a third by mid-year.
• Yoshitsu Co., Ltd TKLF fell 16.8% to close at $3.26.
• Save Foods, Inc. SVFD shares dipped 16.8% to settle at $6.48.
• Aridis Pharmaceuticals, Inc. ARDS fell 16.4% to close at $1.74.
• PetVivo Holdings, Inc. PETV dropped 15.3% to settle at $2.00.
• LianBio LIAN fell 14.7% to settle at $3.82. LianBio recemtly said first patient was dosed in registrational Phase 3 EXPLORER-CN trial of mavacamten in Chinese patients with obstructive hypertrophic cardiomyopathy.
• Immix Biopharma, Inc. IMMX dipped 13.8% to close at $3.55. Immix Biopharma’s IMX-110 + anti-PD-1 produced 63-day median survival in a genetic pancreatic cancer mouse model, in which mice develop their own pancreatic cancer and have an intact immune system.
• Vivos Therapeutics, Inc. VVOS dropped 13.5% to close at $2.43.
• Bone Biologics Corporation BBLG fell 13.1% to close at $2.26.
• Navient Corporation NAVI fell 12.7% to close at $16.17 as the company swung to a loss in the fourth quarter.
• BT Brands, Inc. BTBD fell 10.2% to close at $2.72.
• Studio City International Holdings Limited MSC dipped 9.1% to close at $5.89.
• Automatic Data Processing, Inc. ADP fell 9% to settle at $16.17 after the company reported Q2 earnings results.
• F5, Inc. FFIV shares fell 8.4% to settle at $202.49 after the company issued Q2 sales guidance below estimates.
• Microbot Medical Inc. MBOT fell 7.7% to close at $6.48.